Skip to Main Content

Paper Details

Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol Oncol
2
2024
Author NameAffiliation
Toni K ChoueiriDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2